Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cervical Cancer Recurrent or Persistent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02467907
What this trial is testing

Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer

Who this might be right for
Cervical Cancer
Hoffmann-La Roche 152
Testing effectiveness (Phase 2)Study completedNCT01266460
What this trial is testing

Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+1 more
Gynecologic Oncology Group 54
Large-scale testing (Phase 3)Looking for participantsNCT07472153
What this trial is testing

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Who this might be right for
Metastatic Cervical CancerPersistent Cervical CancerRecurrent Cervical Cancer
N.N. Alexandrov National Cancer Centre 120
Large-scale testing (Phase 3)Enrolling By InvitationNCT06755515
What this trial is testing

A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Shandong New Time Pharmaceutical Co., LTD 510
Testing effectiveness (Phase 2)UnknownNCT01086488
What this trial is testing

Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Ministry of Health, Malaysia 66
Testing effectiveness (Phase 2)Ended earlyNCT00006482
What this trial is testing

Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06882447
What this trial is testing

QL1706 Combined with Nine HPV Vaccine As First-line Treatment for Persistent, Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer Stage IVB
Northern Jiangsu People's Hospital 35
Early research (Phase 1)Study completedNCT01281852
What this trial is testing

Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+2 more
National Cancer Institute (NCI) 37
Large-scale testing (Phase 3)Study completedNCT00770874
What this trial is testing

Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer

Who this might be right for
Cervical Cancer
Taiho Pharmaceutical Co., Ltd. 375
Testing effectiveness (Phase 2)Study completedNCT02921269
What this trial is testing

Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+4 more
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)UnknownNCT05247619
What this trial is testing

A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Zhejiang Cancer Hospital 49
Testing effectiveness (Phase 2)Study completedNCT00691301
What this trial is testing

Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 55
Large-scale testing (Phase 3)UnknownNCT01405235
What this trial is testing

Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma

Who this might be right for
Recurrent, Persistent or Metastasized Cervical Cancer
Institut fuer Frauengesundheit 312
Testing effectiveness (Phase 2)Ended earlyNCT03108495
What this trial is testing

Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma

Who this might be right for
Cervical Carcinoma
Iovance Biotherapeutics, Inc. 210
Testing effectiveness (Phase 2)Study completedNCT00005837
What this trial is testing

Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group
Large-scale testing (Phase 3)UnknownNCT05446883
What this trial is testing

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Who this might be right for
METASTATIC CERVICAL CANCER
Qilu Pharmaceutical Co., Ltd. 498
Testing effectiveness (Phase 2)Ended earlyNCT01958112
What this trial is testing

GSK1120212+GSK2141795 for Cervical Cancer

Who this might be right for
Cervical Cancer
Dana-Farber Cancer Institute 14
Testing effectiveness (Phase 2)Study completedNCT00100789
What this trial is testing

S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 67
Testing effectiveness (Phase 2)Ended earlyNCT00138151
What this trial is testing

Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer

Who this might be right for
Cervical Cancer
University of Medicine and Dentistry of New Jersey 33
Testing effectiveness (Phase 2)Study completedNCT00499031
What this trial is testing

Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical Squamous Cell CarcinomaRecurrent Cervical Carcinoma
Gynecologic Oncology Group 38
Next Page